Full Papers
Expression of miRNAs derived from plasma exosomes in patients with intestinal Behçet’s syndrome
C.-C. Hou1, H.-F. Bao2, Y. Shen3, J.-F. Ye4, H.-F. Ma5, J.-L. Guan6
- Department of Rheumatology and Immunology, Huadong Hospital affiliated to Fudan University, Shanghai, China.
- Department of Rheumatology and Immunology, Huadong Hospital affiliated to Fudan University, Shanghai, China.
- Department of Rheumatology and Immunology, Huadong Hospital affiliated to Fudan University, Shanghai, China.
- Department of Rheumatology and Immunology, Huadong Hospital affiliated to Fudan University, Shanghai, China.
- Department of Rheumatology and Immunology, Huadong Hospital affiliated to Fudan University, Shanghai, China.
- Department of Rheumatology and Immunology, Huadong Hospital affiliated to Fudan University, Shanghai, China. jianlong_guan@126.com
CER14766
2022 Vol.40, N°8
PI 1480, PF 1490
Full Papers
Free to view
(click on article PDF icon to read the article)
PMID: 34665700 [PubMed]
Received: 28/04/2021
Accepted : 01/09/2021
In Press: 19/10/2021
Published: 14/09/2022
Abstract
OBJECTIVES:
MicroRNAs (miRNAs) derived from plasma exosomes are potential diagnostic biomarkers. However, little is known about the expression of miRNAs derived from plasma exosomes in patients with intestinal Behçet’s syndrome (BS). This study aimed to explore the difference of miRNAs derived from plasma exosomes between intestinal BS patients and healthy people, and further identify potential biomarkers that predict the disease activity of intestinal BS.
METHODS:
A total of 43 intestinal BS patients and 23 healthy volunteers were enrolled, among whom 23 were active intestinal BS and 20 were stable intestinal BS. The miRNAs expression profiles of plasma exosomes in 3 active intestinal BS patients and 3 healthy volunteers were determined using next-generation high throughput sequencing. Additionally, significantly differentially expressed miRNAs were further analysed by quantitative real-time polymerase chain reaction (qRT-PCR) in a validation cohort of 60 subjects.
RESULTS:
From the sequencing analysis, 15 miRNAs were identified to be differently expressed (p<0.05). Of these, 13 miRNAs were up-regulated, and 2 were down-regulated in intestinal BS patients compared with healthy volunteers. Furthermore, qRT-PCR analysis confirmed that miR-141-3p was down-regulated and miR-122-5p, miR-150-3p, miR-183-5p, miR-224-5p and miR-342-5p were up-regulated in intestinal BS patients’ plasma exosomes. Additionally, the level of miR-141-3p was negatively correlated with disease activity indicators of intestinal BS, while miR-122-5p, miR-150-3p, miR-183-5p, miR-224-5p and miR-342-5p was positively correlated with disease activity indicators of intestinal BS.
CONCLUSIONS:
Circulating miR-141-3p, miR-122-5p, miR-150-3p, miR-183-5p, miR-224-5p and miR-342-5p derived from plasma exosomes may serve as biomarkers of disease activity in intestinal BS.
